FDA Drug Application (022544) for GRALISE by DEPOMED INC

Back to FDA Applications sponsored by DEPOMED INC

Application Number022544
Product Number001
FormTABLET;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BX Drug products for which the data are insufficient to determine therapeutic equivalence
Reference Drug
Drug NameGRALISE
Active IngredientGABAPENTIN



Back to FDA Applications sponsored by DEPOMED INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.